| VVOS 0.196 -12.85% | CLGN 0.3879 8.35% | PCG 13.27 -20.06% | GPRO 0.8762 46.06% | AIM 0.226 -12.54% | NVDA 220.78 1.48% | TSLL 9.97 11.02% | CNH 11.83 1.28% | RDHL 0.9 36.16% | NVD 3.93 -2.96% | NU 14.55 1.75% | BITO 10.63 1.72% | COOT 0.5928 28.87% | AAL 13.43 -1.54% | FNGR 0.223 -43.97% | INTC 89.51 0.04% | SOAR 0.2325 7.19% | NCRA 2.83 49.74% | SPCX 143.69 1.55% | TSLA 367.95 5.51% | PATH 18.67 2.87% | LGCL 0.0351 -9.77% | ABEV 2.87 0.35% | AEHL 6.49 83.33% | PFE 28.46 1.79% | AMZN 259.77 -2.50% | NIO 4.24 -2.97% | NOK 10.14 -0.69% | BAC 61.94 -0.61% | SNAP 5.55 2.21% | KEEL 3.15 -2.17% | IBIT 44.67 1.75% | TQQQ 71.92 0.10% | WETO 5.48 -4.20% | BMNR 25.32 6.39% | AAPL 316.85 -0.89% | PURR 12.25 5.51% | F 13.94 0.43% | WBUY 0.9 8.43% | ROIV 34.64 -0.20% | IREN 37.115 4.70% | CDE 20.78 -1.66% | SPY 767.05 -0.30% | IONQ 39.31 0.28% | T 25.88 -0.50% | HYG 79.81 0.09% | SOFI 17.88 -1.00% | TLT 82.52 -0.43% | SLB 60.1 4.83% | PLUG 2.16 -1.37%

Northrop Grumman (NYSE:NOC) Stock Declines Amidst Strong Q1 Earnings and Lowered EPS Guidance

Northrop Grumman (NYSE:NOC) is a global aerospace and defense technology company. It operates in various sectors, including aeronautics, defense systems, and space systems, providing advanced solutions to government and commercial customers. On April 23, 2026, a UBS analyst set a new price target on Northrop Grumman at $745, implying a 26.35% potential upside from its price of $589.65 at the time.

Despite this optimistic target, the company's stock price is currently falling. As highlighted by Benzinga, shares are sinking after Northrop Grumman reported its first-quarter earnings. This recent drop follows a 16% stock decline, which has led some to consider the stock a "Strong Buy," as noted by Seeking Alpha, because it is trading below its perceived value.

The company's first-quarter results were strong, beating analyst expectations. Northrop Grumman reported quarterly earnings of $6.14 per share, which was higher than the consensus estimate of $6.09. The company also posted quarterly sales of $9.88 billion, surpassing the analyst estimate of $9.75 billion and showing a 4.36 percent increase from the same quarter a year ago.

The negative market reaction is tied to the company's forecast for the full year. Northrop Grumman affirmed its 2026 adjusted earnings per share (EPS) guidance to be between $27.40 and $27.90. EPS represents the company's profit per share, and this forecast is below the analyst consensus estimate of $28.01, causing concern among investors.

While the company's sales outlook of $43.50 billion to $44 billion is in line with estimates, the lower earnings guidance suggests a "ramp-up year" with muted margin growth. This short-term outlook contrasts with the view that the stock's recent decline presents a valuable buying opportunity, aligning with the significant upside suggested by the UBS price target.

Published on: April 23, 2026